Lifecore Historical Balance Sheet

LFCR Stock

6.60 0.09 1.38%

Trend analysis of Lifecore Biomedical balance sheet accounts such as Total Current Liabilities of 55 M provides information on Lifecore Biomedical's total assets, liabilities, and equity, which is the actual value of Lifecore Biomedical to its prevalent stockholders. By breaking down trends over time using Lifecore Biomedical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Lifecore Biomedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lifecore Biomedical is a good buy for the upcoming year.

Lifecore Biomedical Inventory

26.56 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

About Lifecore Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lifecore Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Lifecore Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lifecore Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lifecore currently owns. An asset can also be divided into two categories, current and non-current.

Lifecore Biomedical Balance Sheet Chart

At this time, Lifecore Biomedical's Cash And Short Term Investments are relatively stable compared to the past year. As of 03/27/2025, Non Current Liabilities Total is likely to grow to about 218.5 M, while Other Current Liabilities is likely to drop slightly above 14.2 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Lifecore Biomedical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Lifecore Biomedical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Lifecore Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lifecore Biomedical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Lifecore Biomedical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lifecore Biomedical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.At this time, Lifecore Biomedical's Cash And Short Term Investments are relatively stable compared to the past year. As of 03/27/2025, Non Current Liabilities Total is likely to grow to about 218.5 M, while Other Current Liabilities is likely to drop slightly above 14.2 M.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	153.1M	130.4M	149.9M	157.4M
Total Assets	295.4M	273.7M	314.8M	248.7M

Short Long Term Debt Total Total Assets

Lifecore Biomedical balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Intangible Assets	Common Stock	Current Deferred Revenue	Short Term Investments
Total Assets		0.6	0.61	0.88	0.76	0.76	0.62	0.48	0.75	-0.61	0.99	-0.73	-0.61	0.48	0.36	0.65	0.13	0.57	0.69	0.85	0.4	0.89	0.31	-0.66	-0.48	-0.66
Short Long Term Debt Total	0.6		0.65	0.69	-0.02	0.88	1.0	-0.3	0.15	-0.71	0.48	-0.56	-0.69	0.52	0.82	0.89	0.39	0.7	0.95	0.83	0.54	0.44	-0.3	-0.41	-0.22	-0.23
Other Current Liab	0.61	0.65		0.5	0.26	0.58	0.65	0.09	0.0	-0.43	0.56	-0.64	-0.44	0.34	0.51	0.63	0.55	0.46	0.63	0.65	0.25	0.24	0.06	-0.39	-0.26	-0.37
Total Current Liabilities	0.88	0.69	0.5		0.61	0.72	0.71	0.4	0.71	-0.64	0.83	-0.71	-0.64	0.27	0.28	0.72	0.24	0.43	0.69	0.9	0.65	0.86	0.26	-0.47	-0.5	-0.53
Total Stockholder Equity	0.76	-0.02	0.26	0.61		0.24	0.0	0.91	0.8	-0.26	0.84	-0.52	-0.28	0.03	-0.28	0.14	-0.03	0.05	0.08	0.45	0.17	0.77	0.63	-0.42	-0.46	-0.64
Property Plant And Equipment Net	0.76	0.88	0.58	0.72	0.24		0.89	-0.13	0.41	-0.78	0.69	-0.53	-0.75	0.63	0.78	0.76	0.14	0.74	0.94	0.77	0.41	0.65	-0.31	-0.58	-0.2	-0.36
Net Debt	0.62	1.0	0.65	0.71	0.0	0.89		-0.28	0.16	-0.76	0.49	-0.57	-0.73	0.51	0.8	0.9	0.4	0.7	0.94	0.84	0.56	0.46	-0.31	-0.41	-0.21	-0.24
Retained Earnings	0.48	-0.3	0.09	0.4	0.91	-0.13	-0.28		0.6	-0.04	0.58	-0.43	-0.08	-0.33	-0.62	-0.09	0.06	-0.29	-0.27	0.22	0.11	0.52	0.72	-0.09	-0.38	-0.46
Accounts Payable	0.75	0.15	0.0	0.71	0.8	0.41	0.16	0.6		-0.22	0.8	-0.39	-0.21	0.22	-0.02	0.18	-0.34	0.18	0.32	0.48	0.2	0.89	0.53	-0.5	-0.46	-0.54
Cash	-0.61	-0.71	-0.43	-0.64	-0.26	-0.78	-0.76	-0.04	-0.22		-0.52	0.51	0.99	-0.33	-0.41	-0.8	-0.44	-0.61	-0.62	-0.73	-0.61	-0.55	0.39	0.25	0.04	0.25
Non Current Assets Total	0.99	0.48	0.56	0.83	0.84	0.69	0.49	0.58	0.8	-0.52		-0.71	-0.53	0.41	0.26	0.52	0.05	0.46	0.6	0.75	0.3	0.89	0.37	-0.63	-0.48	-0.66
Non Currrent Assets Other	-0.73	-0.56	-0.64	-0.71	-0.52	-0.53	-0.57	-0.43	-0.39	0.51	-0.71		0.52	0.01	-0.25	-0.49	-0.47	-0.18	-0.53	-0.68	-0.3	-0.5	-0.22	0.09	0.33	0.22
Cash And Short Term Investments	-0.61	-0.69	-0.44	-0.64	-0.28	-0.75	-0.73	-0.08	-0.21	0.99	-0.53	0.52		-0.33	-0.37	-0.8	-0.45	-0.62	-0.59	-0.73	-0.62	-0.55	0.37	0.24	0.04	0.25
Common Stock Shares Outstanding	0.48	0.52	0.34	0.27	0.03	0.63	0.51	-0.33	0.22	-0.33	0.41	0.01	-0.33		0.68	0.54	-0.22	0.93	0.65	0.43	0.12	0.41	-0.18	-0.79	-0.14	-0.45
Non Current Liabilities Total	0.36	0.82	0.51	0.28	-0.28	0.78	0.8	-0.62	-0.02	-0.41	0.26	-0.25	-0.37	0.68		0.57	0.08	0.69	0.89	0.46	0.09	0.16	-0.46	-0.45	-0.02	-0.07
Inventory	0.65	0.89	0.63	0.72	0.14	0.76	0.9	-0.09	0.18	-0.8	0.52	-0.49	-0.8	0.54	0.57		0.48	0.78	0.78	0.92	0.72	0.55	-0.14	-0.49	-0.31	-0.43
Other Current Assets	0.13	0.39	0.55	0.24	-0.03	0.14	0.4	0.06	-0.34	-0.44	0.05	-0.47	-0.45	-0.22	0.08	0.48		0.05	0.18	0.42	0.6	-0.12	-0.09	0.24	0.03	0.07
Other Stockholder Equity	0.57	0.7	0.46	0.43	0.05	0.74	0.7	-0.29	0.18	-0.61	0.46	-0.18	-0.62	0.93	0.69	0.78	0.05		0.74	0.63	0.36	0.47	-0.27	-0.67	-0.14	-0.41
Total Liab	0.69	0.95	0.63	0.69	0.08	0.94	0.94	-0.27	0.32	-0.62	0.6	-0.53	-0.59	0.65	0.89	0.78	0.18	0.74		0.78	0.38	0.53	-0.22	-0.57	-0.25	-0.3
Total Current Assets	0.85	0.83	0.65	0.9	0.45	0.77	0.84	0.22	0.48	-0.73	0.75	-0.68	-0.73	0.43	0.46	0.92	0.42	0.63	0.78		0.69	0.76	0.16	-0.56	-0.47	-0.56
Short Term Debt	0.4	0.54	0.25	0.65	0.17	0.41	0.56	0.11	0.2	-0.61	0.3	-0.3	-0.62	0.12	0.09	0.72	0.6	0.36	0.38	0.69		0.44	-0.03	-0.2	-0.33	-0.31
Net Receivables	0.89	0.44	0.24	0.86	0.77	0.65	0.46	0.52	0.89	-0.55	0.89	-0.5	-0.55	0.41	0.16	0.55	-0.12	0.47	0.53	0.76	0.44		0.34	-0.66	-0.53	-0.69
Intangible Assets	0.31	-0.3	0.06	0.26	0.63	-0.31	-0.31	0.72	0.53	0.39	0.37	-0.22	0.37	-0.18	-0.46	-0.14	-0.09	-0.27	-0.22	0.16	-0.03	0.34		-0.19	-0.48	-0.43
Common Stock	-0.66	-0.41	-0.39	-0.47	-0.42	-0.58	-0.41	-0.09	-0.5	0.25	-0.63	0.09	0.24	-0.79	-0.45	-0.49	0.24	-0.67	-0.57	-0.56	-0.2	-0.66	-0.19		0.5	0.83
Current Deferred Revenue	-0.48	-0.22	-0.26	-0.5	-0.46	-0.2	-0.21	-0.38	-0.46	0.04	-0.48	0.33	0.04	-0.14	-0.02	-0.31	0.03	-0.14	-0.25	-0.47	-0.33	-0.53	-0.48	0.5		0.57
Short Term Investments	-0.66	-0.23	-0.37	-0.53	-0.64	-0.36	-0.24	-0.46	-0.54	0.25	-0.66	0.22	0.25	-0.45	-0.07	-0.43	0.07	-0.41	-0.3	-0.56	-0.31	-0.69	-0.43	0.83	0.57

Click cells to compare fundamentals

Lifecore Biomedical Account Relationship Matchups

Lifecore Biomedical balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	502.9M	295.2M	295.4M	273.7M	314.8M	248.7M
Short Long Term Debt Total	221.4M	153.2M	153.1M	130.4M	149.9M	157.4M
Other Current Liab	55.0M	16.9M	20.2M	15.5M	17.8M	14.2M
Total Current Liabilities	101.9M	79.2M	79.4M	38.9M	44.7M	55.0M
Total Stockholder Equity	202.8M	107.9M	108.1M	53.9M	62.0M	58.9M
Property Plant And Equipment Net	217.7M	200.4M	139.0M	151.0M	173.7M	182.4M
Net Debt	220.1M	151.5M	151.4M	121.9M	140.2M	147.2M
Retained Earnings	38.6M	(58.9M)	(58.7M)	(166.5M)	(191.5M)	(181.9M)
Accounts Payable	16.3M	15.8M	13.0M	16.3M	18.8M	22.1M
Cash	360K	1.3M	1.6M	8.5M	7.6M	10.6M
Non Current Assets Total	384.2M	354.6M	171.4M	172.9M	198.9M	161.8M
Non Currrent Assets Other	(25.3M)	(26.7M)	3.0M	3.8M	3.4M	3.6M
Cash And Short Term Investments	360K	1.3M	1.6M	8.5M	7.6M	13.1M
Common Stock Shares Outstanding	29.3M	29.5M	29.5M	36.7M	42.2M	26.4M
Liabilities And Stockholders Equity	502.9M	295.2M	295.4M	273.7M	314.8M	248.7M
Non Current Liabilities Total	198.3M	108.0M	107.9M	180.9M	208.1M	218.5M
Inventory	69.7M	66.8M	67.0M	40.0M	46.0M	26.6M
Other Current Assets	42.7M	7.1M	41.4M	1.4M	1.7M	1.6M
Other Stockholder Equity	162.6M	165.5M	167.4M	177.8M	204.5M	121.9M
Total Liab	300.1M	187.2M	187.3M	219.8M	252.8M	265.4M
Total Current Assets	148.3M	123.7M	124.0M	81.0M	93.2M	86.2M
Short Term Debt	30.6M	45.6M	142.5M	4.9M	5.6M	5.4M
Net Receivables	41.4M	48.2M	38.3M	31.2M	35.8M	33.9M
Intangible Assets	38.1M	36.1M	15.6M	4.2M	4.8M	4.6M
Current Deferred Revenue	352K	1.1M	919K	2.1M	1.9M	1.3M
Accumulated Other Comprehensive Income	(2.8M)	(1.4M)	(586K)	(39.2M)	(35.3M)	(33.6M)
Other Liab	14.6M	11.3M	422K	3.5M	3.1M	3.0M
Net Tangible Assets	123.6M	143.2M	78.5M	(19.9M)	(17.9M)	(17.0M)
Other Assets	157.7M	3.0M	3.2M	19.7M	17.8M	25.1M
Long Term Debt	164.9M	97.6M	101.3M	120.5M	138.6M	123.4M
Capital Lease Obligations	27.5M	15.0M	11.0M	9.1M	8.2M	12.9M
Net Invested Capital	396.7M	246.1M	99.9M	132.6M	119.3M	228.8M
Short Long Term Debt	29M	40.6M	488K	773K	695.7K	660.9K
Non Current Liabilities Other	3.6M	190K	3.1M	5.1M	5.8M	3.4M
Net Working Capital	46.4M	44.5M	60.5M	42.2M	48.5M	33.4M
Property Plant Equipment	217.7M	137.4M	139.0M	134.6M	121.1M	132.6M

Additional Tools for Lifecore Stock Analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lifecore Historical Balance Sheet

Lifecore Biomedical Inventory

26.56 Million

About Lifecore Balance Sheet Analysis

Lifecore Biomedical Balance Sheet Chart

Total Assets

Total Current Liabilities

Lifecore Biomedical balance sheet Correlations

Lifecore Biomedical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lifecore Biomedical balance sheet Accounts

Additional Tools for Lifecore Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash
Total Liab	+ 0.95	Short Long Term Debt Total
Total Liab	+ 0.94	Property Plant And Equipment Net
Total Liab	+ 0.94	Net Debt

Inventory	- 0.8	Cash And Short Term Investments
Inventory	- 0.8	Cash
Common Stock	- 0.79	Common Stock Shares Outstanding
Cash	- 0.78	Property Plant And Equipment Net
Cash	- 0.76	Net Debt
Cash And Short Term Investments	- 0.75	Property Plant And Equipment Net